EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acetylcholinesterase inhibitor therapy mitigates hypertension in lupus mice

Paromita Das-Earl, Caroline Gusson Shimoura, Cassandra M Young-Stubbs, Sarika K Chaudhari, Viet Q Dinh, Keisa W Mathis iD

Clinical Science · 13.05.2026 · 140 (5) · 861-881

DOI: 10.1042/cs20250432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 08.05.2026. Verfasst von Paromita Das-Earl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX 75390, U.S.A. Hauptthemen laut MEDLINE: Galantamine, Hypertension, Lupus Erythematosus, Systemic, Cholinesterase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, HHS | National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation is linked to elevated blood pressure, particularly in systemic lupus erythematosus (SLE), where immune dysregulation, hypertension, and renal injury are prevalent. Neural regulation of the immune system helps resolve inflammation, but impaired neuroimmune communication, particularly through reduced activity of the cholinergic anti-inflammatory pathway, may worsen inflammation-driven hypertension. Here, we investigated the effects of long-term systemic administration of the acetylcholinesterase inhibitor galantamine, which is known to enhance neuroimmune communication and the cholinergic anti-inflammatory pathway, on blood pressure, inflammation, and renal injury in SLE mice. Female NZBWF1 mice, a well-established model of SLE, were administered either galantamine (3 mg/kg/day) or saline for 14 consecutive weeks via subcutaneous minipumps and were compared with age-matched and similarly treated NZW control mice. Long-term galantamine treatment improved survival; lowered blood pressure; reduced renal injury markers, including urinary albumin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin; and decreased renal fibrosis in female mice with SLE. Circulating levels of soluble TNFR1, a marker of systemic inflammation and mediator involved in the pathogenesis of cardiovascular disease, were reduced in galantamine-treated SLE mice. Galantamine treatment also reduced splenic CD19+ B cells and kidney CD8+ T cells in SLE mice. Boosting the cholinergic anti-inflammatory pathway with acetylcholinesterase inhibitors such as galantamine alleviates pathological attributes in SLE, including hypertension, inflammation, and renal injury, potentially by modulating B and T cells in the spleen and kidney.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GalantamineHypertensionLupus Erythematosus, SystemicCholinesterase InhibitorsBlood PressureAnimalsFemaleDisease Models, AnimalKidneyMiceMice, Inbred NZB

Stichwörter der Autor:innen

GalantamineSLET regulatory cellscholinergic anti-inflammatory pathway

Substanzen

GalantamineCholinesterase Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX 75390, U.S.A.
  • Department of Physiology and Anatomy, UNT Health Science Center, Fort Worth, TX 76107, U.S.A.

ORCID-Profile: Keisa W Mathis

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • HHS | National Institutes of Health (NIH)
  • U.S. Department of Defense (DOD)

Zitieren

APA

Das-Earl, P., Shimoura, C. G., Young-Stubbs, C. M., Chaudhari, S. K., Dinh, V. Q., & Mathis, K. W. (2026). Acetylcholinesterase inhibitor therapy mitigates hypertension in lupus mice. Clinical Science, 140(5), 861-881. https://doi.org/10.1042/cs20250432

Vancouver

Das-Earl P, Shimoura CG, Young-Stubbs CM, Chaudhari SK, Dinh VQ, Mathis KW. Acetylcholinesterase inhibitor therapy mitigates hypertension in lupus mice. Clinical Science. 2026;140(5):861-881. doi:10.1042/cs20250432

BibTeX
@article{DasEarl2026,
  author = {Das-Earl, Paromita and Shimoura, Caroline Gusson and Young-Stubbs, Cassandra M and Chaudhari, Sarika K and Dinh, Viet Q and Mathis, Keisa W},
  title = {Acetylcholinesterase inhibitor therapy mitigates hypertension in lupus mice},
  journal = {Clinical Science},
  year = {2026},
  volume = {140},
  number = {5},
  pages = {861--881},
  doi = {10.1042/cs20250432}
}
Kostenlos starten →